0
AutoLumo CLIA Autoimmune Markers, 50 Tests × 2(S)
Catalog No :
CAS Number :
Brand :
In Stock
Includes 0.6 mL × 2 vials calibrator
Specifications:
| Application | Chemiluminescent Immunoassay |
| Storage Temperature | 2-8°C |
| Product Type | CLIA Reagent |
| Product Brand | Autobio Diagnostics |
| Product Grade | Medical grade |
The AutoLumo CLIA Autoimmune Marker Microparticles Series provides a comprehensive suite of chemiluminescent immunoassay (CLIA) reagents designed for the quantitative and qualitative detection of autoimmune antibodies in human serum or plasma.
Developed for use with AutoLumo CLIA Analyzers, these magnetic microparticle-based assays offer exceptional sensitivity, specificity, and reproducibility, ensuring accurate detection of autoimmune disorders including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), autoimmune hepatitis (AIH), and autoimmune diabetes (T1DM).
Each reagent kit is supplied with a corresponding calibrator set for consistent assay traceability and precision. All assays are CE marked, meeting international diagnostic standards.
Key Features
- Comprehensive Autoimmune Disease Panel: Covers rheumatology, hepatology, and endocrine autoimmune markers.
- High Analytical Sensitivity: Detects low-titer autoantibodies with precision.
- Magnetic Microparticle CLIA Technology: Ensures stable binding and high signal-to-noise ratio.
- Full Automation Compatibility: Optimized for AutoLumo CLIA analyzers.
- CE-Marked Kits: Suitable for clinical and diagnostic use.
- Includes Calibrators: 0.6 mL × 2 vials per marker for quantitative calibration.
- Reliable and Reproducible: Consistent results across multiple batches and test runs.
Product Range
A. Systemic Autoimmune Markers
| Code | Marker | Description | Pack Size | CE Mark |
|---|---|---|---|---|
| CMQ2310 | Anti-dsDNA IgG | Double-Stranded DNA Antibody CLIA Microparticles | 50T × 2(S) | Yes |
| CMQ2010 | Anti-Sm IgG | Smith Antibody CLIA Microparticles | 50T × 2(S) | Yes |
| CMQ0710 | Anti-SS-A/Ro IgG | SSA/Ro Antibody CLIA Microparticles | 50T × 2(S) | Yes |
| CMQ0810 | Anti-Ro-52 IgG | Ro-52 Antibody CLIA Microparticles | 50T × 2(S) | Yes |
| CMQ0910 | Anti-SS-B IgG | SSB/La Antibody CLIA Microparticles | 50T × 2(S) | Yes |
| CMQ2210 | Anti-rib P IgG | Ribosomal P Protein Antibody CLIA Microparticles | 50T × 2(S) | Yes |
| CMQ1810 | Anti-Scl-70 IgG | Scleroderma (Topoisomerase I) Antibody CLIA Microparticles | 50T × 2(S) | Yes |
| CMQ1910 | Anti-Jo-1 IgG | Jo-1 Antibody CLIA Microparticles | 50T × 2(S) | Yes |
| CMQ3310 | ANA IgG | Antinuclear Antibody CLIA Microparticles | 50T × 2(S) | Yes |
| CMQ1510 | Anti-PR3 IgG | Proteinase 3 Antibody CLIA Microparticles | 50T × 2(S) | Yes |
| CMQ1610 | Anti-MPO IgG | Myeloperoxidase Antibody CLIA Microparticles | 50T × 2(S) | Yes |
B. Hepatobiliary Autoimmune Markers
| Code | Marker | Description | Pack Size | CE Mark |
|---|---|---|---|---|
| CMQ2410 | AMA-M2 IgG | Anti-Mitochondrial M2 Antibody CLIA Microparticles | 50T × 2(S) | Yes |
| CMQ2510 | Anti-gp210 IgG | gp210 Antibody CLIA Microparticles | 50T × 2(S) | Yes |
| CMQ2610 | Anti-sp100 IgG | sp100 Antibody CLIA Microparticles | 50T × 2(S) | Yes |
C. Rheumatoid Arthritis Markers
| Code | Marker | Description | Pack Size | CE Mark |
|---|---|---|---|---|
| CMQ1410 | Anti-CCP IgG | Anti-Cyclic Citrullinated Peptide CLIA Microparticles | 50T × 2(S) | Yes |
| CMQ1010 | RF | Rheumatoid Factor CLIA Microparticles | 50T × 2(S) | Yes |
| CMQ1110 | RF IgM | Rheumatoid Factor IgM CLIA Microparticles | 50T × 2(S) | Yes |
| CMQ1210 | RF IgG | Rheumatoid Factor IgG CLIA Microparticles | 50T × 2(S) | Yes |
| CMQ1310 | RF IgA | Rheumatoid Factor IgA CLIA Microparticles | 50T × 2(S) | Yes |
D. Antiphospholipid Syndrome (APS) Markers
| Code | Marker | Description | Pack Size | CE Mark |
|---|---|---|---|---|
| CMQ3410 | Anti-CL | Anti-Cardiolipin CLIA Microparticles | 50T × 2(S) | Yes |
| CMQ3710 | Anti-CL IgA | Anti-Cardiolipin IgA CLIA Microparticles | 50T × 2(S) | Yes |
| CMQ3510 | Anti-CL IgG | Anti-Cardiolipin IgG CLIA Microparticles | 50T × 2(S) | Yes |
| CMQ3610 | Anti-CL IgM | Anti-Cardiolipin IgM CLIA Microparticles | 50T × 2(S) | Yes |
| CMQ2910 | Anti-β2-GP1 | Beta-2 Glycoprotein I Antibody CLIA Microparticles | 50T × 2(S) | Yes |
| CMQ3010 | Anti-β2-GP1 IgA | Beta-2 Glycoprotein I IgA CLIA Microparticles | 50T × 2(S) | Yes |
| CMQ3110 | Anti-β2-GP1 IgG | Beta-2 Glycoprotein I IgG CLIA Microparticles | 50T × 2(S) | Yes |
| CMQ3210 | Anti-β2-GP1 IgM | Beta-2 Glycoprotein I IgM CLIA Microparticles | 50T × 2(S) | Yes |
E. Autoimmune Diabetes Markers
| Code | Marker | Description | Pack Size | CE Mark |
|---|---|---|---|---|
| CMQ2710 | GADA | Glutamic Acid Decarboxylase Antibody CLIA Microparticles | 50T × 2(S) | Yes |
| CMQ2810 | IAA | Insulin Autoantibody CLIA Microparticles | 50T × 2(S) | Yes |
| CMQ3810 | IA-2A | Insulinoma-Associated Protein 2 Antibody CLIA Microparticles | 50T × 2(S) | Yes |
| CMQ3910 | ICA | Islet Cell Antibody CLIA Microparticles | 50T × 2(S) | Yes |
Calibrators
Each assay includes a corresponding calibrator kit (0.6 mL × 2 vials) to ensure accurate quantitative analysis and reliable standardization across test runs.
Clinical Applications
- Rheumatology: Diagnosis and monitoring of rheumatoid arthritis and connective tissue diseases.
- Systemic Autoimmune Disorders: Screening for lupus, Sjögren’s syndrome, and scleroderma.
- Endocrine Autoimmunity: Detection of type 1 diabetes-related antibodies.
- Hepatic Autoimmunity: Evaluation of autoimmune hepatitis and primary biliary cholangitis.
- Thrombosis & APS: Identification of antiphospholipid antibodies for clotting disorders.
- Autoantibody Profiling: Comprehensive autoimmune panel for multi-system evaluation.
Performance Characteristics
- Detection Method: Chemiluminescent Immunoassay (CLIA)
- Technology: Magnetic Microparticle-Based Sandwich Immunoassay
- Sample Type: Human Serum or Plasma
- Precision: Coefficient of Variation (CV) ≤ 10%
- Storage: 2–8°C, protected from light
- Shelf Life: 12 months from manufacturing date
Unique Advantages
- Broad autoimmune marker coverage across multiple disease systems.
- CE-marked and traceable calibrators included for each marker.
- Fully automated on AutoLumo CLIA analyzers.
- High sensitivity for early detection and differential diagnosis.
- Reliable solution for clinical immunology and rheumatology laboratories.
The AutoLumo CLIA Autoimmune Marker Microparticles Series delivers a complete range of high-sensitivity assays for autoimmune antibody detection using chemiluminescent immunoassay technology.
Engineered for accuracy, reproducibility, and automation, this series supports comprehensive autoimmune profiling in clinical, endocrine, and immunology laboratories.
A trusted solution for precise, CE-certified autoimmune testing across rheumatologic, hepatic, and metabolic disorders using AutoLumo CLIA analyzers.
- Target Marker: Double-Stranded DNA Antibody (Anti-dsDNA IgG) Smith Antibody (Anti-Sm IgG) Anti-SS-A/Ro IgG Anti-Ro-52 IgG SSB/La Antibody (Anti-SS-B IgG) Ribosomal P Protein Antibody (Anti-rib P IgG) Scleroderma (Topoisomerase I) Antibody (Anti-Scl-70 IgG) Jo-1 Antibody (Anti-Jo-1 IgG) Antinuclear Antibody (ANA IgG ) Proteinase 3 Antibody (Anti-PR3 IgG) Myeloperoxidase Antibody (Anti-MPO IgG) Anti-Mitochondrial M2 Antibody (AMA-M2 IgG) gp210 Antibody (Anti-gp210 IgG) sp100 Antibody (Anti-sp100 IgG) Anti-Cyclic Citrullinated Peptide (Anti-CCP IgG) Rheumatoid Factor (RF) Rheumatoid Factor IgM (RF IgM) Rheumatoid Factor IgG (RF IgG ) Rheumatoid Factor IgA (RF IgA) Anti-Cardiolipin (Anti-CL) Anti-Cardiolipin IgA (Anti-CL IgA) Anti-Cardiolipin IgG (Anti-CL IgG) Anti-Cardiolipin IgM (Anti-CL IgM) Beta-2 Glycoprotein I Antibody (Anti-β2-GP1) Beta-2 Glycoprotein I IgA (Anti-β2-GP1 IgA) Beta-2 Glycoprotein I IgG (Anti-β2-GP1 IgG) Beta-2 Glycoprotein I IgM (Anti-β2-GP1 IgM) Glutamic Acid Decarboxylase Antibody (GADA) Insulin Autoantibody (IAA) Insulinoma-Associated Protein 2 Antibody (IA-2A) Islet Cell Antibody (ICA)